Proteomics International: Raises $6M for high-tech blood test

  • Proteomics International (PIQ) has received firm commitments to undertake a $6 million share placement
  • 12.5 million shares will issued to sophisticated and professional investors at 48 cents each
  • Additionally, the company will issue 2.2 million options to Euroz Hartleys Securities and Candour Advisory
  • These options will have an exercise price of 75 cents with expiry two years after issue
  • Proteomics will also use the funds to manufacture, market, and speed-up regulatory approvals for its PromarkerD test and strengthen its balance sheet
  • Proteomics is up 9 per cent on the market with shares trading for 60 cents each
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Revolut Strengthens Presence with Indian Hiring Spree

The financial technology company seeks to expand its team in India.Highlights: Revolut is launching a significant hiring campaign...

Visa Strengthens Subscription Management Service for Businesses

New solutions aim to simplify recurring payment management for companies.Highlights: Visa has launched a new subscription management service.The...

Mastercard to Sell Nets Payments Unit Following $3.2 Billion Acquisition

The divestment follows Mastercard's strategic review of its portfolio.Highlights: Mastercard is set to sell its Nets payments unit.The...

Mastercard Seeks to Offload Payments Unit It Acquired for $32 Billion

The proposed sale comes as Mastercard re-evaluates its payments strategy.Highlights: Mastercard aims to sell its payments unit, originally...